• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interpreting Geographic Variations in Results of Randomized, Controlled Trials.

作者信息

Yusuf Salim, Wittes Janet

机构信息

From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada (S.Y.); and Statistics Collaborative, Washington, DC (J.W.).

出版信息

N Engl J Med. 2016 Dec 8;375(23):2263-2271. doi: 10.1056/NEJMra1510065.

DOI:10.1056/NEJMra1510065
PMID:27959693
Abstract
摘要

相似文献

1
Interpreting Geographic Variations in Results of Randomized, Controlled Trials.解读随机对照试验结果中的地域差异
N Engl J Med. 2016 Dec 8;375(23):2263-2271. doi: 10.1056/NEJMra1510065.
2
International differences in treatment effect: do they really exist and why?国际间治疗效果的差异：它们真的存在吗？原因是什么？
Eur Heart J. 2013 Jun;34(24):1846-52. doi: 10.1093/eurheartj/eht071. Epub 2013 Mar 7.
3
[Heart Protection Study].[心脏保护研究]
Ugeskr Laeger. 2002 Jan 14;164(3):348.
4
[Establishment of J-MIC (Japan-Multicenter Investigation for Cardiovascular Drugs/Therapies)].[日本心血管药物/治疗多中心研究（J-MIC）的建立]
Jpn Circ J. 1994;58 Suppl 4:1301-4. doi: 10.1253/jcj.58.supplementiv_1301.
5
Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.随机对照降压试验在高血压治疗中的批判性再评价
Circ Res. 2015 Mar 13;116(6):1058-73. doi: 10.1161/CIRCRESAHA.116.303641.
6
Lessons from the ACCOMPLISH trial.来自ACCOMPLISH试验的经验教训。
Pol Arch Med Wewn. 2009 Jun;119(6):344-6.
7
Reflections on early stopping of a clinical trial.关于临床试验提前终止的思考
Am Heart J. 2006 Sep;152(3):407-9. doi: 10.1016/j.ahj.2006.06.006.
8
[ONTARGET, PROFESS, TRANSCEND large scale studies. AT1 blockers: evidence based advantage, but less than expected].[ONTARGET、PROFESS、TRANSCEND大规模研究。血管紧张素Ⅱ1型受体阻滞剂：基于证据的优势，但低于预期]
MMW Fortschr Med. 2008 Sep 18;150(38):14, 16.
9
Atorvastatin therapy reduces serum uric acid levels: a meta-analysis of randomized controlled trials.阿托伐他汀治疗可降低血清尿酸水平：一项随机对照试验的荟萃分析。
Int J Cardiol. 2012 May 31;157(2):255-7. doi: 10.1016/j.ijcard.2012.01.092. Epub 2012 Feb 21.
10
[E-COST].[电子成本]
Nihon Rinsho. 2006 Aug;64 Suppl 6:480-5.

引用本文的文献

1
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence data.AncestryGeni：一种用于小且有噪声序列数据的新型遗传血统分类流程。
Bioinformatics. 2025 Jul 1;41(7). doi: 10.1093/bioinformatics/btaf391.
2
The impact of liver transplantation on endpoint selection in alcohol-associated hepatitis trials.肝移植对酒精性肝炎试验中终点选择的影响。
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000709. eCollection 2025 May 1.
3
A Response to: Letter to the Editor Regarding "Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance".
对《致编辑的信：关于托法替布与肿瘤坏死因子抑制剂安全性和有效性的地理差异：ORAL Surveillance的事后分析》的回复
Rheumatol Ther. 2025 Apr;12(2):403-405. doi: 10.1007/s40744-024-00739-1. Epub 2025 Jan 20.
4
Factors associated with placebo response rate in randomized controlled trials of antiseizure medications for focal epilepsy.局灶性癫痫抗癫痫药物随机对照试验中与安慰剂反应率相关的因素。
Epilepsia. 2025 Feb;66(2):407-416. doi: 10.1111/epi.18197. Epub 2024 Dec 21.
5
Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.房颤消融与药物治疗疗效的区域差异：CABANA试验结果
Am Heart J. 2024 Apr;270:103-116. doi: 10.1016/j.ahj.2024.01.009. Epub 2024 Feb 1.
6
Indian dyslipidaemia guidelines: Need of the hour.《印度血脂异常指南：当下之需》
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S2-S5. doi: 10.1016/j.ihj.2024.01.008. Epub 2024 Jan 12.
7
Increasing challenges to trial recruitment and conduct over time.随着时间的推移，试验招募和实施面临的挑战越来越大。
Epilepsia. 2023 Oct;64(10):2625-2634. doi: 10.1111/epi.17716. Epub 2023 Jul 25.
8
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PROTECT Randomized Clinical Trial of ESA-Naïve Patients.非透析依赖型慢性肾脏病患者中，瓦达司他与达贝泊汀α的安全性终点：ESA初治患者PROTECT随机临床试验的事后区域分析
Kidney Med. 2023 May 12;5(7):100666. doi: 10.1016/j.xkme.2023.100666. eCollection 2023 Jul.
9
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With NonDialysis-Dependent CKD: A Post Hoc Regional Analysis of the PROTECT Randomized Clinical Trial of ESA-Treated Patients.非透析依赖性慢性肾脏病患者中，vadadustat与阿法达贝泊汀的安全性终点：ESA治疗患者PROTECT随机临床试验的事后区域分析
Kidney Med. 2023 May 12;5(7):100667. doi: 10.1016/j.xkme.2023.100667. eCollection 2023 Jul.
10
Health Care Utilization Following Interventions to Improve Social Well-Being: A Systematic Review and Meta-analysis.干预措施改善社会福祉后医疗保健的利用：系统评价和荟萃分析。
JAMA Netw Open. 2023 Jun 1;6(6):e2321019. doi: 10.1001/jamanetworkopen.2023.21019.